• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsConsumer DefensivesPersonal & Household Products & ServicesNeoPharm
    Picture of NeoPharm logo

    092730 — NeoPharm Share News

    KR₩23,3000.000.00%
    kr flag iconLast trade - 00:00
    Consumer DefensivesAdventurousSmall CapSuper Stock
    • Market Cap
      KR₩364bn
    • Enterprise Value
      KR₩221bn
    • Revenue
      KR₩132bn
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • 092730 Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    092730 Dividends
    • Brief: Neopharm Q4 Operating Profit 7.2 Billion Won, Up 8% From Year Earlier

      27/01/2026 07:06
    • Brief: Neopharm Q1 Operating Profit 7.8 Billion Won, Up 14.6% From Year Earlier

      09/05/2025 08:11
    • Brief: Neopharm Q4 Operating Profit 6.7 Billion Won, Down 3.8% From Year Earlier

      04/02/2025 07:01
    • Brief: Neopharm Q2 Operating Profit 6.1 Billion Won, Down 2.7% From Year Earlier

      02/08/2024 08:27
    • Brief: Neopharm Q1 Operating Profit 7 Billion Won, Down 3.5% From Year Earlier

      03/05/2024 08:27
    • Brief: Neopharm Q4 Operating Profit 7 Billion Won, Up 15.4% From Year Earlier

      02/02/2024 07:24
    • Brief: Neopharm Q3 Operating Profit 5 Billion Won, Up 22% From Year Earlier

      03/11/2023 08:47
    • Brief: Neopharm Q2 Operating Profit 6.3 Billion Won, Up 27% From Year Earlier

      04/08/2023 12:35
    • Brief: Neopharm receives patent

      20/06/2018 08:21
    • Brief: Neopharm to pay annual cash dividend as 500 won/share for 2017

      13/03/2018 03:50
    • Brief: Neopharm to pay annual dividend as 350 won/share for FY 2016

      17/02/2017 03:40
    • Brief: Neopharm changes CEO to Lee Dae Yeol

      30/12/2016 03:10

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.